Company Comparison
Bluebird Bio vs AI Therapeutics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Bluebird Bio | AI Therapeutics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Somerville, MA | San Diego |
| Founded | 2010 | — |
| Status | Active | Active |
| Last Funding Stage | IPO | Series A |
| Total Funding | $1.2B | $48M |
| Valuation | — | — |
What They Build
Bluebird Bio
Biotechnology company developing gene therapies for severe genetic diseases and cancer using advanced gene editing technologies.
AI Therapeutics
A San Diego biotech company using AI to accelerate drug discovery and development processes.
Key Investors
Bluebird Bio
AI Therapeutics
No investors listed.
Sector Overlap
Both Bluebird Bio and AI Therapeutics operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.